🔎 Trials Near Me

Beranda › PPOK › Florida › Miami

Uji klinis PPOK di Miami, FL

18 studi untuk PPOK mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Menerima pesertaFase 3
  • Elite Clinical Research - Miami- Site Number : 8400167, Miami
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • dan 3 lainnya
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Menerima pesertaFase 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07684820

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Menerima pesertaFase 2
  • Millennium Medical Research - Miami, Miami
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07780656

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Menerima pesertaFase 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Menerima pesertaFase 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • dan 1 lainnya
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Menerima pesertaFase 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • dan 2 lainnya
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Menerima pesertaFase 3
  • Research Site, Miami
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Menerima pesertaFase 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Menerima pesertaFase 2/3
  • Reed Medical Research, Miami
Usia 35 hingga 80 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07363694

Rademikibart IV for Acute Asthma and COPD Exacerbation

Menerima pesertaFase 2
  • Columbus Clinical Services, LLC, Miami
  • Pharmax Research of South Florida, Inc., Miami
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07705737

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Menerima pesertaFase 3
  • Research Site, Miami
  • Research Site, Miami
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06283966

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Menerima peserta
  • University of Miami, Miami
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06578156

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • dan 4 lainnya
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Menerima pesertaFase 3
  • GSK Investigational Site, Miami
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 8 Okt 2025 · NCT06959095

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Menerima peserta
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2025 · NCT05204888

Uji klinis PPOK di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.